Hims & Hers Health logo

Hims & Hers Health(HIMS)

Emerging

Telehealth platform with $872M 2024 revenue; GLP-1 weight loss, hair, and sexual health prescriptions shipped directly to 2M+ subscribers; went public via SPAC merger in 2021;

35
AI Score
Grade D↑ Trending
AI Visibility Score (Beta)
HealthcareHIMSWebsiteUpdated March 2026
Customers
2M

Company Overview

About Hims & Hers Health

Hims & Hers Health is a telehealth and wellness platform offering personalized treatment plans and prescription medications for conditions including hair loss, erectile dysfunction, weight management, skincare, and mental health. Founded in 2017 and headquartered in San Francisco, Hims & Hers went public via SPAC merger in January 2021 and has grown into a $1B+ revenue publicly traded health company. The platform connects patients with licensed providers asynchronously and ships prescription treatments directly to homes, eliminating the friction of in-person doctor visits for lifestyle health conditions.

Business Model & Competitive Advantage

The company generated $872 million in revenue in 2024, growing over 40% year-over-year, driven significantly by its GLP-1 weight loss program which launched prescriptions for compounded semaglutide as Ozempic and Wegovy supply shortages created massive demand. Hims & Hers enrolled hundreds of thousands of weight loss subscribers in 2024, fundamentally changing its revenue mix and growth trajectory. The company serves over 2 million subscribers across its product lines.

Competitive Landscape 2025–2026

In 2025, Hims & Hers faces regulatory uncertainty around compounded GLP-1 medications as the FDA has moved to restrict compounding once brand-name shortages are resolved. The company has been diversifying its weight management portfolio and investing in its broader personalized health platform. Hims & Hers continues to expand its mental health (therapy, psychiatry) and women's health offerings while navigating the complex regulatory landscape of telehealth prescribing. Revenue is projected at $1.2B+ in 2025 as the company deepens patient relationships beyond single-condition treatments.

Founded
2017
Headquarters
San Francisco, Hims
Customers
2M
Curated content • Fact-checked and verified

Recent Activity

View all →

Key Differentiators

Emerging Innovator

Hims & Hers Health is an emerging player bringing innovative solutions to the Healthcare market.

Massive User Base

Trusted by 2M worldwide, demonstrating broad market appeal and proven reliability.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

35
↑ Trending

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Browser Use logo

Browser Use

Developer Tools
B2bDeveloper ToolsPlatformSaasStartup

Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

Idexx Laboratories logo

Idexx Laboratories

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu

Revvity logo

Revvity

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid

GE HealthCare logo

GE HealthCare

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designin

Incyte logo

Incyte

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company — publicly traded on the NASDAQ (NASDAQ: INCY) as an S&P 500 Health Care component — focused on oncology and inflammation,

For Hims & Hers Health

Claim This Profile

Are you from Hims & Hers Health? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Hims & Hers Health Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Hims & Hers Health vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →